SCHEMBL274608

SCHEMBL274608

NC1CCCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11045780 1.00
SCHEMBL2672536 0.97
SCHEMBL273524 0.90
SCHEMBL285898 0.69
SCHEMBL957744 0.68
SCHEMBL8040334 0.67
SCHEMBL554844 0.65
SCHEMBL2680016 0.62
SCHEMBL2040534 0.62
SCHEMBL119292 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092773-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES UCB Biopharma SRL (BE) 2024-03-21 US claimed
US-20230399320-A1 NOVEL CAPSID ASSEMBLY INHIBITOR Pelemed Co., Ltd. (UA) 2023-12-14 US claimed
EP-4242203-A1 NOVEL CAPSID ASSEMBLY INHIBITOR Pelemed Co., Ltd. (KR) 2023-09-13 EP claimed
US-20230279001-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN-LA ROCHE INC. (US) 2023-09-07 US claimed
CN-116507611-A Novel capsid assembly inhibitor 佩勒梅德有限公司 2023-07-28 CN claimed
EP-4192588-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2023-06-14 EP claimed
EP-4182032-A1 HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2023-05-24 EP claimed
EP-3856737-B1 HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN LA ROCHE (CH) 2023-05-17 EP claimed
US-11639352-B2 Benzothiazole compounds for the treatment of autoimmune diseases HOFFMAN-LA ROCHE INC. (US) 2023-05-02 US claimed
CN-115835910-A Hydrogenated isoquinoline or naphthyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2023-03-21 CN claimed
EP-0778731-B1 IONENE POLYMERS CONTAINING BIOLOGICALLY-ACTIVE ANIONS BUCKMAN LABOR INC (US) 2000-03-29 EP claimed
CN-1212694-A Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production THOMAE GMBH DR K (DE) 1999-03-31 CN claimed
CN-1212696-A Pyrimido [5, 4-d ] pyrimidines, medicaments containing these compounds, their use and processes for their preparation THOMAE GMBH DR K (DE) 1999-03-31 CN claimed
EP-0778731-A1 IONENE POLYMERS CONTAINING BIOLOGICALLY-ACTIVE ANIONS BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1997-06-18 EP claimed
US-5575993-A USEFUL AS HERBICIDES, MICROBIOCIDES, PLANT GROWTH REGULATORS, PHARMACEUTICALS, DISINFECTANTS, ALGICIDES, SANITIZERS, AND PRESERVATIVES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1996-11-19 US claimed
WO-1996006528-A1 IONENE POLYMERS CONTAINING BIOLOGICALLY-ACTIVE ANIONS BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1996-03-07 WO claimed
EP-0333175-B1 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-ene-2-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO (JP) 1994-06-15 EP claimed
US-5202437-A Bactericides, antibiotics, microbiocides FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1993-04-13 US claimed
US-4925838-A CARBAPENICILLINS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 US claimed
EP-0333175-A1 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-ene-2-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-09-20 EP claimed